In Vivo Glucose Transporter-2 Regulation of Dorsomedial Versus Ventrolateral VMN Astrocyte Metabolic Sensor and Glycogen Metabolic Enzyme Gene Expression in Female Rat

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2024 Sep 21

PMID 39306597

Authors

Sagor C Roy

Subash Sapkota

Madhu Babu Pasula

Karen P Briski

Affiliations

Soon will be listed here.

Abstract

Astrocyte glycogenolysis shapes ventromedial hypothalamic nucleus (VMN) regulation of glucostasis in vivo. Glucose transporter-2 (GLUT2), a plasma membrane glucose sensor, controls hypothalamic primary astrocyte culture glycogen metabolism in vitro. In vivo gene silencing tools and single-cell laser-catapult-microdissection/multiplex qPCR techniques were used here to examine whether GLUT2 governs dorsomedial (VMNdm) and/or ventrolateral (VMNvl) VMN astrocyte metabolic sensor and glycogen metabolic enzyme gene profiles. GLUT2 gene knockdown diminished astrocyte GLUT2 mRNA in both VMN divisions. Hypoglycemia caused GLUT2 siRNA-reversible up-regulation of this gene profile in the VMNdm, but down-regulated VMNvl astrocyte GLUT2 transcription. GLUT2 augmented baseline VMNdm and VMNvl astrocyte glucokinase (GCK) gene expression, but increased (VMNdm) or reduced (VMNvl) GCK transcription during hypoglycemia. GLUT2 imposed opposite control, namely stimulation versus inhibition of VMNdm or VMNvl astrocyte 5'-AMP-activated protein kinase-alpha 1 and -alpha 2 gene expression, respectively. GLUT2 stimulated astrocyte glycogen synthase (GS) gene expression in each VMN division. GLUT2 inhibited transcription of the AMP-sensitive glycogen phosphorylase (GP) isoform GP-brain type (GPbb) in each site, yet diminished (VMNdm) or augmented (VMNvl) astrocyte GP-muscle type (GPmm) mRNA. GLUT2 enhanced VMNdm and VMNvl glycogen accumulation during euglycemia, and curbed hypoglycemia-associated VMNdm glycogen depletion. Results show that VMN astrocytes exhibit opposite, division-specific GLUT2 transcriptional responsiveness to hypoglycemia. Data document divergent GLUT2 control of GCK, AMPK catalytic subunit, and GPmm gene profiles in VMNdm versus VMNvl astrocytes. Ongoing studies seek to determine how differential GLUT2 regulation of glucose and energy sensor function and glycogenolysis in each VMN location may affect local neuron responses to hypoglycemia.

Citing Articles

Ventromedial hypothalamic nucleus neuronal nitric oxide knockdown effects on GABAergic neuron metabolic sensor and transmitter marker gene expression in the male rat.

Roy S, Pasula M, Sapkota S, Briski K BMC Neurosci. 2025; 26(1):14.

PMID: 39994513 PMC: 11853586. DOI: 10.1186/s12868-025-00940-0.

References

Alhamyani A, Napit P, Bheemanapally K, Ibrahim M, Sylvester P, Briski K . Glycogen phosphorylase isoform regulation of glucose and energy sensor expression in male versus female rat hypothalamic astrocyte primary cultures. Mol Cell Endocrinol. 2022; 553:111698. PMC: 9332090. DOI: 10.1016/j.mce.2022.111698. View

Alhamyani A, Napit P, Bheemanapally K, Sylvester P, Briski K . Singular versus combinatory glucose-sensitive signal control of metabolic sensor protein profiles in hypothalamic astrocyte cultures from each sex. Transl Neurosci. 2022; 13(1):408-420. PMC: 9719392. DOI: 10.1515/tnsci-2022-0259. View

Alho H, Costa E, Ferrero P, Fujimoto M, Guidotti A . Diazepam-binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain. Science. 1985; 229(4709):179-82. DOI: 10.1126/science.3892688. View

Haider Ali M, Alshamrani A, Napit P, Briski K . Single-cell multiplex qPCR evidence for sex-dimorphic glutamate decarboxylase, estrogen receptor, and 5'-AMP-activated protein kinase alpha subunit mRNA expression by ventromedial hypothalamic nucleus GABAergic neurons. J Chem Neuroanat. 2022; 124:102132. PMC: 9474596. DOI: 10.1016/j.jchemneu.2022.102132. View

Argente-Arizon P, Guerra-Cantera S, Garcia-Segura L, Argente J, Chowen J . Glial cells and energy balance. J Mol Endocrinol. 2016; 58(1):R59-R71. DOI: 10.1530/JME-16-0182. View

Auer R . Hypoglycemic brain damage. Forensic Sci Int. 2004; 146(2-3):105-10. DOI: 10.1016/j.forsciint.2004.08.001. View

Bheemanapally K, Briski K . Differential G Protein-Coupled Estrogen Receptor-1 Regulation of Counter-Regulatory Transmitter Marker and 5'-AMP-Activated Protein Kinase Expression in Ventrolateral versus Dorsomedial Ventromedial Hypothalamic Nucleus. Neuroendocrinology. 2023; 114(1):25-41. PMC: 10843453. DOI: 10.1159/000533627. View

Bouyakdan K, Martin H, Lienard F, Budry L, Taib B, Rodaros D . The gliotransmitter ACBP controls feeding and energy homeostasis via the melanocortin system. J Clin Invest. 2019; 129(6):2417-2430. PMC: 6546475. DOI: 10.1172/JCI123454. View

Briski K, Marshall E, Sylvester P . Effects of estradiol on glucoprivic transactivation of catecholaminergic neurons in the female rat caudal brainstem. Neuroendocrinology. 2001; 73(6):369-77. DOI: 10.1159/000054655. View

10.

Briski K, Napit P, Alhamyani A, Leprince J, Mahmood A . Sex-Dimorphic Octadecaneuropeptide (ODN) Regulation of Ventromedial Hypothalamic Nucleus Glucoregulatory Neuron Function and Counterregulatory Hormone Secretion. ASN Neuro. 2023; 15:17590914231167230. PMC: 10196551. DOI: 10.1177/17590914231167230. View

11.

Butcher R, Collins W, FUGO N . Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology. 1974; 94(6):1704-8. DOI: 10.1210/endo-94-6-1704. View

12.

Donovan C, Watts A . Peripheral and central glucose sensing in hypoglycemic detection. Physiology (Bethesda). 2014; 29(5):314-24. PMC: 4214828. DOI: 10.1152/physiol.00069.2013. View

13.

Douglass J, Dorfman M, Thaler J . Glia: silent partners in energy homeostasis and obesity pathogenesis. Diabetologia. 2016; 60(2):226-236. PMC: 5253392. DOI: 10.1007/s00125-016-4181-3. View

14.

Ferrero P, Santi M, Costa E, Guidotti A . Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Proc Natl Acad Sci U S A. 1986; 83(3):827-31. PMC: 322958. DOI: 10.1073/pnas.83.3.827. View

15.

Guidotti A, Forchetti C, Corda M, Konkel D, Bennett C, Costa E . Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci U S A. 1983; 80(11):3531-5. PMC: 394079. DOI: 10.1073/pnas.80.11.3531. View

16.

Guillemain G, Loizeau M, Pincon-Raymond M, Girard J, Leturque A . The large intracytoplasmic loop of the glucose transporter GLUT2 is involved in glucose signaling in hepatic cells. J Cell Sci. 2000; 113 ( Pt 5):841-7. DOI: 10.1242/jcs.113.5.841. View

17.

Hamed S . Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications. Expert Rev Clin Pharmacol. 2017; 10(4):409-428. DOI: 10.1080/17512433.2017.1293521. View

18.

Han S, Namkoong C, Jang P, Park I, Hong S, Katakami H . Hypothalamic AMP-activated protein kinase mediates counter-regulatory responses to hypoglycaemia in rats. Diabetologia. 2005; 48(10):2170-8. DOI: 10.1007/s00125-005-1913-1. View

19.

Huynh M, Kinyua A, Yang D, Kim K . Hypothalamic AMPK as a Regulator of Energy Homeostasis. Neural Plast. 2016; 2016:2754078. PMC: 4980534. DOI: 10.1155/2016/2754078. View

20.

Ibrahim M, Alhamami H, Briski K . Norepinephrine regulation of ventromedial hypothalamic nucleus metabolic transmitter biomarker and astrocyte enzyme and receptor expression: Impact of 5' AMP-activated protein kinase. Brain Res. 2019; 1711:48-57. PMC: 6430699. DOI: 10.1016/j.brainres.2019.01.012. View